Levi (LEVI) October option IV flat into quarter results

Go back to Levi (LEVI) October option IV flat into quarter results

Levi Strauss & Co. (LEVI) PT Lowered to $19 at Morgan Stanley

October 3, 2024 3:00 PM UTC

Morgan Stanley analyst Alex Straton lowered the price target on Levi Strauss & Co. (NYSE: LEVI) to $19.00 (from $20.00) while maintaining a Equalweight rating.

The analyst comments "Revenue shortcomings were offset by strong margins, making for a slight EPS beat. Post-print de-rating seemingly accounts for challenging... More

Levi Strauss & Co. (LEVI) PT Lowered to $25 at Stifel

October 3, 2024 5:49 AM UTC

Stifel analyst Jim Duffy lowered the price target on Levi Strauss & Co. (NYSE: LEVI) to $25.00 (from $28.00) while maintaining a Buy rating.

The analyst comments "FY3Q results again feature strong indicators of brand health (DTC acceleration, strong GM upside) packaged with disappointing... More

Citi Reiterates Neutral Rating on Levi Strauss & Co. (LEVI)

October 3, 2024 5:41 AM UTC

Citi analyst Paul Lejuez reiterated a Neutral rating and $21.00 price target on Levi Strauss & Co. (NYSE: LEVI).

The analyst comments "LEVI again posted a bottom-line beat, but like 2Q, sales were weaker than consensus. Despite the beat in the qtr, mgmt... More

BofA Securities Reiterates Neutral Rating on Levi Strauss & Co. (LEVI)

October 3, 2024 5:34 AM UTC

BofA Securities analyst Christopher Nardone reiterated a Neutral rating and $22.00 price target on Levi Strauss & Co. (NYSE: LEVI).

The analyst comments "We reiterate our Neutral rating; we think valuation fairly reflects the continued momentum in Levis brand DTC sales. LEVI reported 3Q... More